Phase 0/microdosing approaches: time for mainstream application in drug development?
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase 0/microdosing approaches: time for mainstream application in drug development?
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-10
DOI
10.1038/s41573-020-0080-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxaliplatin-DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy
- (2020) Maike Zimmermann et al. MOLECULAR CANCER THERAPEUTICS
- Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions
- (2020) Alvaro A. Ordonez et al. NATURE MEDICINE
- Pilot Study to Predict Pharmacokinetics of a Therapeutic Gemcitabine Dose From a Microdose
- (2020) M. Van Nuland et al. Clinical Pharmacology in Drug Development
- Application of a microdosed cocktail of three oral factor Xa inhibitors to study drug‐drug interactions with different perpetrator drugs
- (2020) Gerd Mikus et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Multiplexed evaluation of microdosed antineoplastic agents in situ in the tumor microenvironment of patients with soft tissue sarcoma
- (2020) Kenneth R Gundle et al. CLINICAL CANCER RESEARCH
- How do the pharmacokinetics of drugs change in astronauts in space?
- (2020) Sara Eyal Expert Opinion on Drug Metabolism & Toxicology
- The endless frontier? The recent increase of R&D productivity in pharmaceuticals
- (2020) Fabio Pammolli et al. Journal of Translational Medicine
- Probes and Cocktails for Drug-Drug Interaction Evaluation: The Future Is Microdosing?
- (2019) Gerd Mikus CLINICAL PHARMACOLOGY & THERAPEUTICS
- Predictive Value of Microdose Pharmacokinetics
- (2019) Merel van Nuland et al. CLINICAL PHARMACOKINETICS
- Prediction of Human Nonlinear Pharmacokinetics of a New Bcl-2 Inhibitor Using PBPK Modeling and Interspecies Extrapolation Strategy
- (2019) Philippe B. Pierrillas et al. DRUG METABOLISM AND DISPOSITION
- The biodistribution and clearance of AlbudAb, a novel biopharmaceutical medicine platform, assessed via PET imaging in humans
- (2019) Kevin S. Thorneloe et al. EJNMMI Research
- Dose‐linearity of the pharmacokinetics of an intravenous [ 14 C]midazolam microdose in children
- (2019) Bianca D. Groen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Simultaneous phenotyping of CYP2E1 and CYP3A using oral chlorzoxazone and midazolam microdoses
- (2019) Nicolas Hohmann et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A Phase 0 Trial of Ribociclib in Recurrent Glioblastoma Patients Incorporating a Tumor Pharmacodynamic- and Pharmacokinetic-Guided Expansion Cohort
- (2019) An-Chi Tien et al. CLINICAL CANCER RESEARCH
- Off-Label Prescribing in Children Remains High: A Call for Prioritized Research
- (2019) Katelyn Yackey et al. PEDIATRICS
- Medications in Space: In Search of a Pharmacologist’s Guide to the Galaxy
- (2019) Sara Eyal et al. PHARMACEUTICAL RESEARCH
- Estimation of clinical trial success rates and related parameters
- (2018) Chi Heem Wong et al. BIOSTATISTICS
- Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma Patients
- (2018) Nader Sanai et al. CLINICAL CANCER RESEARCH
- Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective
- (2018) Mohamad Shebley et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Importance of target-mediated drug disposition for small molecules
- (2018) Dennis A. Smith et al. DRUG DISCOVERY TODAY
- A Clinical Quantitative Evaluation of Hepatobiliary Transport of [11C]Dehydropravastatin in Humans Using Positron Emission Tomography
- (2018) Ken-ichi Kaneko et al. DRUG METABOLISM AND DISPOSITION
- Preclinical characterization of three transient receptor potential vanilloid receptor 1 antagonists for early use in human intradermal microdose analgesic studies
- (2018) E. Sjögren et al. EUROPEAN JOURNAL OF PAIN
- Ultra-sensitive LC–MS/MS method for the quantification of gemcitabine and its metabolite 2′,2′-difluorodeoxyuridine in human plasma for a microdose clinical trial
- (2018) M. van Nuland et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Developing a cassette microdosing approach to enhance the throughput of PET imaging agent screening
- (2018) Hao Xiao et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Microdosing Cocktail Assay Development for Drug–Drug Interaction Studies
- (2018) Cynthia M. Chavez-Eng et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Impact of a five-dimensional framework on R&D productivity at AstraZeneca
- (2018) Paul Morgan et al. NATURE REVIEWS DRUG DISCOVERY
- Impact of target interactions on small-molecule drug disposition: an overlooked area
- (2018) Robert A. B. van Waterschoot et al. NATURE REVIEWS DRUG DISCOVERY
- A diagnostic microdosing approach to investigate platinum sensitivity in non-small cell lung cancer
- (2017) Si-Si Wang et al. INTERNATIONAL JOURNAL OF CANCER
- The Use of Microdosing in the Development of Small Organic and Protein Therapeutics
- (2017) Mats Bergstrom JOURNAL OF NUCLEAR MEDICINE
- An ultra-sensitive LC–MS/MS method to determine midazolam levels in human plasma: development, validation and application to a clinical study
- (2017) Mu Chen et al. Bioanalysis
- Drug–drug interaction of microdose and regular-dose omeprazole with a CYP2C19 inhibitor and inducer
- (2017) Gab-jin Park et al. Drug Design Development and Therapy
- Quantifying Carbon-14 for Biology Using Cavity Ring-Down Spectroscopy
- (2016) A. Daniel McCartt et al. ANALYTICAL CHEMISTRY
- Preclinical Characterization and Human Microdose Pharmacokinetics of ITMN-8187, a Nonmacrocyclic Inhibitor of the Hepatitis C Virus NS3 Protease
- (2016) Ravi Rajagopalan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A phase 0 clinical trial of novel candidate extended-release formulations of capecitabine
- (2016) Bart A.W. Jacobs et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Human Microdosing with Carcinogenic Polycyclic Aromatic Hydrocarbons: In Vivo Pharmacokinetics of Dibenzo[def,p]chrysene and Metabolites by UPLC Accelerator Mass Spectrometry
- (2016) Erin P. Madeen et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Parallel In Vivo Assessment of Drug Phenotypes at Various Time Points during Systemic BRAF Inhibition Reveals Tumor Adaptation and Altered Treatment Vulnerabilities
- (2016) O. Jonas et al. CLINICAL CANCER RESEARCH
- Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study
- (2016) Laetitia E. Lamberts et al. CLINICAL CANCER RESEARCH
- Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels
- (2016) Hannah M. Jones et al. CLINICAL PHARMACOKINETICS
- Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A
- (2016) T Prueksaritanont et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development
- (2016) T Burt et al. CTS-Clinical and Translational Science
- Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans – a practical guide
- (2016) Tal Burt et al. Expert Opinion on Drug Delivery
- Small-Molecule Compounds Exhibiting Target-Mediated Drug Disposition (TMDD): A Minireview
- (2016) Guohua An JOURNAL OF CLINICAL PHARMACOLOGY
- Innovation in the pharmaceutical industry: New estimates of R&D costs
- (2016) Joseph A. DiMasi et al. JOURNAL OF HEALTH ECONOMICS
- Vision 20/20: Molecular-guided surgical oncology based upon tumor metabolism or immunologic phenotype: Technological pathways for point of care imaging and intervention
- (2016) Brian W. Pogue et al. MEDICAL PHYSICS
- Microdose-Induced Drug–DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice
- (2016) Maike Zimmermann et al. MOLECULAR CANCER THERAPEUTICS
- Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions
- (2016) Ana Luiza Ribeiro de Souza et al. MOLECULAR IMAGING AND BIOLOGY
- Toxicity and Pharmacokinetic Profile for Single-Dose Injection of ABY-029: a Fluorescent Anti-EGFR Synthetic Affibody Molecule for Human Use
- (2016) Kimberley S. Samkoe et al. MOLECULAR IMAGING AND BIOLOGY
- Microdose fluorescence imaging of ABY-029 on an operating microscope adapted by custom illumination and imaging modules
- (2016) Jonathan T. Elliott et al. Biomedical Optics Express
- Validation of a liquid chromatography-triple quadrupole mass spectrometric method for the determination of 5-nitro-5′-hydroxy-indirubin-3′-oxime (AGM-130) in human plasma and its application to microdose clinical trial
- (2015) Min-Ho Park et al. BIOMEDICAL CHROMATOGRAPHY
- Midazolam microdose to determine systemic and pre-systemic metabolic CYP3A activity in humans
- (2015) Nicolas Hohmann et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Observational infant exploratory [14C]-paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis
- (2015) Colin R. Garner et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A clinical pharmacokinetic microdosing study of docetaxel with Japanese patients with cancer
- (2015) Ken-ichi Fujita et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- To Apply Microdosing or Not? Recommendations to Single Out Compounds with Non-Linear Pharmacokinetics
- (2015) Sieto Bosgra et al. CLINICAL PHARMACOKINETICS
- Pediatric microdose and microtracer studies using14C in Europe
- (2015) MA Turner et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Microdosing Studies in Children: A US Regulatory Perspective
- (2015) M Roth-Cline et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Mechanistic understanding of the nonlinear pharmacokinetics and intersubject variability of simeprevir: A PBPK-guided drug development approach
- (2015) J Snoeys et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Microdosing of a Carbon-14 Labeled Protein in Healthy Volunteers Accurately Predicts Its Pharmacokinetics at Therapeutic Dosages
- (2015) MLH Vlaming et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Ethical Considerations in Conducting Pediatric and Neonatal Research in Clinical Pharmacology
- (2015) Michelle Roth-Cline et al. CURRENT PHARMACEUTICAL DESIGN
- EANM’15
- (2015) EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Large Variation in Brain Exposure of Reference CNS Drugs: a PET Study in Nonhuman Primates
- (2015) Magnus Schou et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Intraarterial Microdosing: A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats
- (2015) T. Burt et al. JOURNAL OF NUCLEAR MEDICINE
- An Assessment of the Oral Bioavailability of Three Ca-Channel Blockers Using a Cassette-Microdose Study: A New Strategy for Streamlining Oral Drug Development
- (2015) Shinji Yamashita et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Why is it hard to terminate failing projects in pharmaceutical R&D?
- (2015) Richard W. Peck et al. NATURE REVIEWS DRUG DISCOVERY
- Progression-seeking bias and rational optimism in research and development
- (2015) Dennis W. Lendrem et al. NATURE REVIEWS DRUG DISCOVERY
- The Cost of Drug Development
- (2015) Joseph A. DiMasi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of rapid multistep carbon-11 radiosynthesis of the myeloperoxidase inhibitor AZD3241 to assess brain exposure by PET microdosing
- (2015) Peter Johnström et al. NUCLEAR MEDICINE AND BIOLOGY
- An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors
- (2015) Oliver Jonas et al. Science Translational Medicine
- Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer
- (2015) Azeem Saleem et al. EJNMMI Research
- Use of Microdosing and Accelerator Mass Spectrometry To Evaluate the Pharmacokinetic Linearity of a Novel Tricyclic GyrB/ParE Inhibitor in Rats
- (2014) Michael A. Malfatti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Human in Vivo Pharmacokinetics of [14C]Dibenzo[def,p]chrysene by Accelerator Mass Spectrometry Following Oral Microdosing
- (2014) Erin Madeen et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Pediatric Microdose Study of [14C]Paracetamol to Study Drug Metabolism Using Accelerated Mass Spectrometry: Proof of Concept
- (2014) Miriam G. Mooij et al. CLINICAL PHARMACOKINETICS
- Response to “Can CYP3A Activity Be Evaluated for Drug Interaction Using a Nanogram Dose of Probe Drug?”: Evaluation of CYP3A Activity With Microdoses of Midazolam
- (2014) N Hohmann et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetic analysis of14C-ursodiol in newborn infants using accelerator mass spectrometry
- (2014) Toufigh Gordi et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A decade of innovation in pharmaceutical R&D: the Chorus model
- (2014) Paul K. Owens et al. NATURE REVIEWS DRUG DISCOVERY
- Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
- (2014) David Cook et al. NATURE REVIEWS DRUG DISCOVERY
- Adverse drug reactions and off-label and unlicensed medicines in children: a nested case?control study of inpatients in a pediatric hospital
- (2013) Jennifer R Bellis et al. BMC Medicine
- First-in-Human Phase 0 Trial of Oral 5-Iodo-2-Pyrimidinone-2'-Deoxyribose in Patients with Advanced Malignancies
- (2013) S. Kummar et al. CLINICAL CANCER RESEARCH
- A Nanogram Dose of the CYP3A Probe Substrate Midazolam to Evaluate Drug Interactions
- (2013) B Halama et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cost-effectiveness Analysis of Microdose Clinical Trials in Drug Development
- (2013) Naoe Yamane et al. Drug Metabolism and Pharmacokinetics
- A microdose study of 14C-AR-709 in healthy men: pharmacokinetics, absolute bioavailability and concentrations in key compartments of the lung
- (2013) G. Lappin et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Preclinical evaluation of BAY 1075553, a novel 18F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer
- (2013) Ralf Lesche et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Microdose pharmacogenetic study of 14C-tolbutamide in healthy subjects with accelerator mass spectrometry to examine the effects of CYP2C9∗3 on its pharmacokinetics and metabolism
- (2013) Toshihiko Ikeda et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- AFN-1252 in vitro absorption studies and pharmacokinetics following microdosing in healthy subjects
- (2013) Nachum Kaplan et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Microdosing and drug development: past, present and future
- (2013) Graham Lappin et al. Expert Opinion on Drug Metabolism & Toxicology
- Mechanisms of Pharmacokinetic Enhancement Between Ritonavir and Saquinavir; Micro/Small Dosing Tests Using Midazolam (CYP3A4), Fexofenadine (p-Glycoprotein), and Pravastatin (OATP1B1) as Probe Drugs
- (2013) Ichiro Ieiri et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Phase 0 Microdosing PET Study Using the Human Mini Antibody F16SIP in Head and Neck Cancer Patients
- (2013) D. A. Heuveling et al. JOURNAL OF NUCLEAR MEDICINE
- Power failure: why small sample size undermines the reliability of neuroscience
- (2013) Katherine S. Button et al. NATURE REVIEWS NEUROSCIENCE
- Radiolabeling of the cannabinoid receptor agonist AZD1940 with carbon-11 and PET microdosing in non-human primate
- (2013) Magnus Schou et al. NUCLEAR MEDICINE AND BIOLOGY
- Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study
- (2013) Anthony Cahn et al. BMC Pharmacology & Toxicology
- Positron Emission Tomography as a Method for Measuring Drug Delivery to Tumors in vivo: The Example of [11C]docetaxel
- (2013) Astrid A. M. van der Veldt et al. Frontiers in Oncology
- Quantification of femtomolar concentrations of the CYP3A substrate midazolam and its main metabolite 1′-hydroxymidazolam in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry
- (2012) Jürgen Burhenne et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Ultrasensitive Liquid Chromatography–Tandem Mass Spectrometric Methodologies for Quantification of Five HIV-1 Integrase Inhibitors in Plasma for a Microdose Clinical Trial
- (2012) Li Sun et al. ANALYTICAL CHEMISTRY
- Human microdose evaluation of the novel EP1 receptor antagonist GSK269984A
- (2012) Thor Ostenfeld et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Predicting Drug Candidate Victims of Drug-Drug Interactions, using Microdosing
- (2012) Marie Croft et al. CLINICAL PHARMACOKINETICS
- A positron emission tomography microdosing study with sertraline in healthy volunteers
- (2012) Kwang-Hee Shin et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Pharmacogenomic/pharmacokinetic assessment of a four-probe cocktail for CYPs and OATPs following oral microdosing
- (2012) Ichiro Ieiri et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Biphasic Elimination of Tenofovir Diphosphate and Nonlinear Pharmacokinetics of Zidovudine Triphosphate in a Microdosing Study
- (2012) Jianmeng Chen et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Combining PET Biodistribution and Equilibrium Dialysis Assays to Assess the Free Brain Concentration and BBB Transport of CNS Drugs
- (2012) Roger N Gunn et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- PET Imaging-Based Evaluation of Hepatobiliary Transport in Humans with (15R)-11C-TIC-Me
- (2012) T. Takashima et al. JOURNAL OF NUCLEAR MEDICINE
- Microdosing: A Critical Assessment of Human Data
- (2012) Malcolm Rowland JOURNAL OF PHARMACEUTICAL SCIENCES
- High-sensitive LC-MS/MS method for the simultaneous determination of mirodenafil and its major metabolite, SK-3541, in human plasma: Application to microdose clinical trials of mirodenafil
- (2012) Doo-Yeoun Cho et al. JOURNAL OF SEPARATION SCIENCE
- Diagnosing the decline in pharmaceutical R&D efficiency
- (2012) Jack W. Scannell et al. NATURE REVIEWS DRUG DISCOVERY
- Applications of accelerator MS in pediatric drug evaluation
- (2012) LT Vuong et al. Bioanalysis
- Iodine-129 microdosing for protein and peptide drug development: erythropoietin as a case study
- (2012) Robert-Jan AN Lamers et al. Bioanalysis
- Evaluation of Physical and Chemical Changes in Pharmaceuticals Flown on Space Missions
- (2011) Brian Du et al. AAPS Journal
- Ethical, legal, and social implications (ELSI) of microdose clinical trials
- (2011) Chieko Kurihara ADVANCED DRUG DELIVERY REVIEWS
- Novel strategies for microdose studies using non-radiolabeled compounds
- (2011) Kazuya Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668
- (2011) J. M. Reid et al. Cancer Prevention Research
- Pgp-Mediated Interaction Between (R)-[11C]Verapamil and Tariquidar at the Human Blood–Brain Barrier: A Comparison With Rat Data
- (2011) M Bauer et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Nonlinear Pharmacokinetics of Oral Quinidine and Verapamil in Healthy Subjects: A Clinical Microdosing Study
- (2011) K Maeda et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effects of a MATE Protein Inhibitor, Pyrimethamine, on the Renal Elimination of Metformin at Oral Microdose and at Therapeutic Dose in Healthy Subjects
- (2011) H Kusuhara et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Identification of the Rate-Determining Process in the Hepatic Clearance of Atorvastatin in a Clinical Cassette Microdosing Study
- (2011) K Maeda et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
- (2011) Paul Morgan et al. DRUG DISCOVERY TODAY
- Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls
- (2011) Henryk Barthel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers
- (2011) Graham Lappin et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The cost of drug development: A systematic review
- (2011) Steve Morgan et al. HEALTH POLICY
- Microdosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1), and Interaction (Grapefruit Juice) Profiles of Celiprolol Following the Oral Microdose and Therapeutic Dose
- (2011) Ichiro Ieiri et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Lead PK Commentary: Predicting Human Pharmacokinetics
- (2011) Malcolm Rowland et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- A highly sensitive LC-MS/MS method capable of simultaneously quantitating celiprolol and atenolol in human plasma for a cassette cold-microdosing study
- (2011) Yoshiyuki Minamide et al. JOURNAL OF SEPARATION SCIENCE
- How were new medicines discovered?
- (2011) David C. Swinney et al. NATURE REVIEWS DRUG DISCOVERY
- The productivity crisis in pharmaceutical R&D
- (2011) Fabio Pammolli et al. NATURE REVIEWS DRUG DISCOVERY
- Extrapolation of Adult Data and Other Data in Pediatric Drug-Development Programs
- (2011) J. Dunne et al. PEDIATRICS
- Clinical Relevance of Liquid Chromatography Tandem Mass Spectrometry as an Analytical Method in Microdose Clinical Studies
- (2011) Naoe Yamane et al. PHARMACEUTICAL RESEARCH
- Pharmacokinetic and pharmacogenomic profiles of telmisartan after the oral microdose and therapeutic dose
- (2011) Ichiro Ieiri et al. Pharmacogenetics and Genomics
- Case studies addressing human pharmacokinetic uncertainty using a combination of pharmacokinetic simulation and alternative first in human paradigms
- (2011) Anthony Harrison et al. XENOBIOTICA
- Radiopharmaceutical chemistry for positron emission tomography
- (2010) Zibo Li et al. ADVANCED DRUG DELIVERY REVIEWS
- Impact of microdosing clinical study — Why necessary and how useful?
- (2010) Yuichi Sugiyama et al. ADVANCED DRUG DELIVERY REVIEWS
- Quantifying exploratory low dose compounds in humans with AMS
- (2010) Stephen R. Dueker et al. ADVANCED DRUG DELIVERY REVIEWS
- Approaches using molecular imaging technology — use of PET in clinical microdose studies
- (2010) Claudia C. Wagner et al. ADVANCED DRUG DELIVERY REVIEWS
- The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part III: The three microdose candidates
- (2010) Jane L. Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A Combined Accelerator Mass Spectrometry-Positron Emission Tomography Human Microdose Study with 14C- and 11C-Labelled Verapamil
- (2010) Claudia C. Wagner et al. CLINICAL PHARMACOKINETICS
- Microdose Study of 14C-Acetaminophen With Accelerator Mass Spectrometry to Examine Pharmacokinetics of Parent Drug and Metabolites in Healthy Subjects
- (2010) Z Tozuka et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
- (2010) J A DiMasi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetics of fexofenadine: Evaluation of a microdose and assessment of absolute oral bioavailability
- (2010) Graham Lappin et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- A microdosing approach for characterizing formation and repair of carboplatin-DNA monoadducts and chemoresistance
- (2010) Paul T. Henderson et al. INTERNATIONAL JOURNAL OF CANCER
- Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS
- (2010) A. Yamazaki et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Pharmacodynamic (Phase 0) Study Using Etaracizumab in Advanced Melanoma
- (2010) Stergios J. Moschos et al. JOURNAL OF IMMUNOTHERAPY
- How to improve R&D productivity: the pharmaceutical industry's grand challenge
- (2010) Steven M. Paul et al. NATURE REVIEWS DRUG DISCOVERY
- Microdosing for early biokinetic studies in humans
- (2010) K. Stenstrom et al. RADIATION PROTECTION DOSIMETRY
- Human microdosing for the prediction of patient response
- (2010) Paul T Henderson et al. Bioanalysis
- Sensitivity and proportionality assessment of metabolites from microdose to high dose in rats using LC–MS/MS
- (2010) Jinsong Ni et al. Bioanalysis
- Practical experience of using human microdosing with AMS analysis to obtain early human drug metabolism and PK data
- (2010) R Colin Garner Bioanalysis
- Early human ADME using microdoses and microtracers: bioanalytical considerations
- (2010) Stephen R Dueker et al. Bioanalysis
- Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug Development
- (2009) Masato Chiba et al. AAPS Journal
- A pharmacokinetic evaluation of five H1antagonists after an oral and intravenous microdose to human subjects
- (2009) Ajay Madan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effective Use of Microdosing and Positron Emission Tomography (PET) Studies on New Drug Discovery and Development
- (2009) Yuichi Sugiyama Drug Metabolism and Pharmacokinetics
- Microdose Clinical Trial: Quantitative Determination of Nicardipine and Prediction of Metabolites in Human Plasma
- (2009) Naoe Yamane et al. Drug Metabolism and Pharmacokinetics
- Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies
- (2009) Shivaani Kummar et al. JOURNAL OF CLINICAL ONCOLOGY
- Microdose Pharmacokinetics of IDX899 and IDX989, Candidate HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors, Following Oral and Intravenous Administration in Healthy Male Subjects
- (2009) Xiao-Jian Zhou et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Lessons from 60 years of pharmaceutical innovation
- (2009) Bernard Munos NATURE REVIEWS DRUG DISCOVERY
- Traversing the Valley of Death: A Guide to Assessing Prospects for Translational Success
- (2009) B. S. Coller et al. Science Translational Medicine
- Microdosing Studies in Humans
- (2008) Martin Bauer et al. Drugs in research & development
- Use of Accelerator Mass Spectrometry to Measure the Pharmacokinetics and Peripheral Blood Mononuclear Cell Concentrations of Zidovudine
- (2007) Le T. Vuong et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now